Katacalcin is a recently discovered
peptide, contained within the
calcitonin precursor. For the highly sensitive radioimmunological measurement of
katacalcin and
calcitonin we used extraction on C-18, thereby lowering the detection limits in serum to 0.8 pmol/l (
katacalcin) and 0.7 pmol/l (
calcitonin), and simultaneously improving the specificities of both assays for the monomeric forms of the
peptides. Extraction recoveries were greater than 96% and greater than 95% for pure monoiodinated [125I]Tyr(0)-
katacalcin and [125I]
calcitonin, respectively; and 95-98% and 91-97% respectively for the corresponding unlabelled
peptides. This method is sufficiently sensitive and specific for studies on the physiology of both
peptides. Gel filtration of serum from a patient with
medullary carcinoma of the thyroid showed that the majority of high molecular weight forms of
katacalcin and
calcitonin did not bind to C-18, and that the eluted material consisted to more than 90% of monomeric
katacalcin and
calcitonin. Basal levels (mean +/- SEM) of
katacalcin were higher in men (3.0 +/- 0.6 pmol/l, age less than 40 years, and 1.8 +/- 0.4 pmol/l, age greater than 40 years) and younger women (2.1 +/- 0.4 pmol/l) than in older women (1.3 +/- 0.6 pmol/l; p less than 0.02). The respective values for
calcitonin were 5.1 +/- 0.9 and 4.0 +/- 0.6 pmol/l for young and older men, and 2.3 +/- 0.4 and 2.8 +/- 0.8 pmol/l for young and older women, with a significant sex-related difference in both age groups. Basal serum levels of
katacalcin and
calcitonin were highly correlated (
katacalcin = 0.66
calcitonin -0.12 pmol/l; p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)